|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | ||||
| Stock-based compensation | ||||
| Non-cash exploration expense | ||||
| Non-cash research and development expense | ||||
| Non-cash exploration and research and development expense | ||||
| Loss on de-recognition of mineral interest | ||||
| Interest expense | ||||
| Unrealized foreign exchange loss (gain) | ||||
| Share of losses from significant influence investments | ||||
| Gain on disposal of subsidiary | ||||
| Loss on revaluation of investments, net | ||||
| Loss on revaluation of convertible debt | ||||
| Provision for expected credit loss | ||||
| Impairment | ||||
| Income taxes | ||||
| Other | ||||
| Changes in other operating assets and liabilities: | ||||
| Trade accounts receivable | ||||
| Inventory | ||||
| Operating lease liabilities | ||||
| Accounts payable and accrued liabilities | ||||
| Deferred exploration liability | ||||
| Other operating assets and liabilities | ||||
| Net cash used in operating activities | ||||
| Investing activities | ||||
| Purchase of exploration properties | ||||
| Deposits paid for property, plant and equipment | ||||
| Purchase of investments subject to significant influence | ||||
| Proceeds from sale of a subsidiary | ||||
| Cash acquired on acquisition of subsidiary | ||||
| Net cash provided by (used in) investing activities | ||||
| Financing activities | ||||
| Net proceeds from issuance of common stock | ||||
| Promissory note payment | ||||
| Proceeds from related party loan | ||||
| Proceeds from convertible notes | ||||
| Repayment of related party loan | ||||
| Non-controlling interests investment in subsidiary | ||||
| Proceeds from exercise of stock options and warrants | ||||
| Taxes paid on net settlement of RSU's | ||||
| Debt issuance costs | ||||
| Other | ||||
| Net cash provided by financing activities | ||||
| Effect of foreign exchange rate changes on cash and cash equivalents | ||||
| Increase (decrease) in cash and cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash, beginning of the year | ||||
| Cash, cash equivalents and restricted cash, end of the year | ||||
| Restricted cash, end of the year | ||||
| Cash and cash equivalents, end of the year | ||||
| Supplemental cash flow information | ||||
| Interest paid | ||||
| Cash paid for income taxes | ||||
| Supplemental disclosure of non-cash investing and financing activities | ||||
| Issuance of common stock | ||||
| Non-controlling interests investment in subsidiary | ||||
| Settlement of related party loan | ||||
| Note payable issued as consideration for land purchase | ||||
| Settlement of loan upon issuance of shares of subsidiary | ||||
| Issuance of common stock upon conversion of debt | ||||
| Issuance of common stock upon settlement of liability | ||||
Loading...